Hamid Trimech is a Process Engineer with over 10 years of experience in GMP facility construction, technology transfers and vaccine manufacturing. He is currently Project Manager in Business Development at ARCALIS Inc., a Japan-based CDMO specialized in mRNA therapeutics and vaccines. Hamid began his career at Sanofi Pasteur in France, where he contributed to multiple vaccine drug substance projects. Over the past decade, he has contributed to more than 15 vaccine manufacturing projects in Europe, Asia, and Latin America. At ARCALIS, he initially led engineering and MSAT activities, overseeing facility design and construction, mRNA/LNP drug substance and drug product technology transfer and process validation. Notably, he played a key role in the tech transfer of two COVID-19 vaccines in Japan, a recombinant protein-based vaccine and a self-amplifying mRNA (Sa-mRNA) vaccine. He now focuses on client engagement and global project coordination, supporting biotech and pharmaceutical clients from early development to GMP manufacturing.